Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats

Research in Experimental Medicine - Tập 179 - Trang 153-161 - 1981
Autar K. Walli1, D. Seidel1
1Dept. of Clinical Chemistry, Center of Internal Medicine, University of Göttingen, Göttingen, Federal Republic of Germany

Tóm tắt

Administration of clofibric acid and bezafibrate to rats lowers plasma lipids, increases the liver weight, and causes a slight decrease in the activity of alkaline phosphatase in plasma. However, both these drugs increase the activity of alkaline phosphatase in liver over threefold. The activity of other enzymes did not change by the same magnitude. The increase in the alkaline phosphatase activity in liver tissue appears to be due to increase in the activity of this enzyme in parenchymal cells. Clofibric acid and bezafibrate increase the activity of bilirubin-glucuronyl transferase activity over twofold in liver microsomes. It is thus evident that both these drugs cause similar changes in various enzyme activities in liver even though bezafibrate has been reported to have a much shorter biologic halflife than clofibric acid.

Tài liệu tham khảo

Abshagen U, Bablok W, Koch K, Lang PD, Schmidt HAE, Stork H (1979) Disposition pharmacokinetics of bezafibrate in man. Eur J Clin Pharmacol 16:31–38

Ahmed Z, King EJ (1959) Placental phosphatases. Biochim Biophys Acta 34:313–325

Anthony L, Schmucker D, Mooney J, Jones A (1978) A quantitative analysis of fine structure and drug metabolism in livers of clofibrate-treated young adult and retired breeder rats. J Lipid Res 19:154–165

Avoy DR, Swyrd EA, Gould RG (1965) Effects ofα-p-chlorophenoxyisobutyrylethyl ester (CPIB) with and without androsterone biosynthesis in liver. J Lipid Res 6:369–376

Bergmeyer HU (1970) In: Methoden der enzymatischen Analyse, Vol I, II. Verlag Chemie, Weinheim, Bergstraße

Berndt J, Gaumert R, Still J (1978) Mode of action of lipid-lowering agents, clofibrate and BM 15075 on cholesterol biosynthesis in rat liver. Atherosclerosis 30:147–152

Berry MN, Friend DS (1969) High-yield preparation of isolated liver parenchymal cells. A biochemical and fine structural study. J Cell Biol 43:506–520

Best MM, Duncan CH (1964) Hypolipemia and hepatomegaly from ethyl chlorophenoxyisobutyrate (CPIB) in the rat. J Lab Clin Med 64:634–642

Bolzano K, Krempler F, Schellenberg B, Schlierf (1979) In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 134–136

Burch RE, Curran GL (1969) Hepatic acetoacetyl-CoA deacylase activity in rats fed ethyl chlorophenoxyisobutyrate (CPIB). J Lipid Res 10:668–673

Fahimi HD, Kalmbach P, Stegmeier K, Stork H (1979) In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 66–77

Foliot A, Drocourt J-L, Etienne JP, Housset E, Fiessinger JN, Christoforov B (1977) Increase in the hepatic glucuronidation and clearance of bilirubin in clofibrate-treated rats. Biochem Pharmacol 26:547–549

Gear RL, Albert AD, Bednarek (1974) The effect of hypocholesterolemic drug clofibrate on liver mitochondrial biogenesis. J Biol Chem 249:6495–6504

Hellman L, Zumoff B, Kessler G, Kara E, Rubin IL, Rosenfeld RS (1963) Reduction of cholesterol and lipids in man by ethyl-chlorophenoxyisobutyrate. Ann Int Med 59:477–493

Hess R, Stäubli W, Reiss W (1965) Nature of hepatomegalic effect produced by ethylchlorophenoxyisobutyrate in the rat. Nature 208:856–858

Hodson AW, Latner AL, Raine L (1961) Isoenzymes of alkaline phosphatase. Clin Chim Acta 7:255–261

Kaplan MM, Righetti A (1970) Induction of rat liver alkaline phosphatase, the mechanism of serum elevation in bile duct obstruction. J Clin Invest 49:508–516

Lazarow P (1978) Rat liver peroxisomes catalyze theβ-oxidation of fatty acids. J Biol Chem 253:1522–1528

Lazarow P (1979) In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 100–104

Lazarow P, de-Duve C (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes, enhancements by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 73:2043–2046

Lowry OH, Rosebrough NJ, Farr L, Randall RJ (1951) Protein measurement with folin-phenol reagent. J Biol Chem 193:265–275

Moss DW, Walli AK (1969) Intermediates in the hydrolysis of ATP by human alkaline phosphatase. Biochem Biophys Acta 191:476–477

Nordlie RC, Arion WJ (1966) In: Colowick SP, Kaplan NO (eds) Methods in enzymology, vol 9. Academic Press, New York, p 619

Omura T, Sato R (1964) The carbon monoxide binding pigment of liver microsomes. Solubilization, purification and its properties. J Biol Chem 239:2379–2385

Platt DS, Thorp JM (1966) Changes in the weight and composition of liver in the rat, dog and monkey treated with chlorophenoxyisobutyrate. Biochem Pharmacol 15:915–925

Posen S (1967) Alkaline phosphatase. Ann Int Med 67:183–202

Reddy J, Krishnakantha T (1975) Hepatic peroxisome proliferation. Induction by two novel compounds structurally unrelated to clofibrate. Science 190:787–789

Roy FP van, Heirwegh KPM (1968) Determination of bilirubin glucuronide and assay of glucuronyltransferase with bilirubin as acceptor. Biochem J 107:507–518

Schade RWB, Demacker PNM, Van'T Laar A (1975) Reduction of serum alkaline phosphatase by clofibrate. Lancet I:862–863

Schade RWB, Demacker PNM, Van'T Laar A (1977) Clofibrate effect on alkaline phosphatase. Bone or liver fraction. N Engl J Med 297:669

Schimassek H (1963) Metabolite des Kohlenhydratstoffwechsels der isoliert perfundierten Rattenleber. Biochem Z 336:460–467

Schimassek H, Hofer G, Walli AK (1971) In: Martini GA, Bode Ch (eds) Metabolic changes induced by alcohol. Springer, Heidelberg, pp 157–165

Stegmeier K, Stork H, Lenz H, Leuschner F, Liede V (1979) In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 78–84

Walli AK, Birkmann K, Schimassek H (1974) Glycogen metabolism in isolated rat parenchymal cells. Hoppe Seylers Z Physiol Chem 355:1264

Walli AK, Schimassek H (1976) Glycogen metabolism in isolated parenchymal cells. In: Tager JM, Söling HD, Williamson JR (eds) Use of isolated liver cells and kidney tubules in metabolic studies. North Holland Publ Co, Amsterdam, pp 426–429

Whitaker KB, Costa D, Moss DW (1979) Selective effects of clofibrate on alkaline phosphatase isoenzymes in serum. Clin Chim Acta 94:191–196

White LW (1971) Regulation of hepatic cholesterol biosynthesis by clofibrate administration. J Pharmacol Exp Ther 178:361–370

Wilkinson JH (1965) In: Isoenzymes. E & FN Spon Ltd, London, pp 104–119

Wootton AM, Neale G, Moss DW (1975) Some properties of alkaline phosphatases in parenchymal and biliary tract cells separated from rat liver. Clin Chim Acta 61:183–190

Zumoff B (1977) Effect of clofibrate on plasma levels of alkaline phosphatase. N Engl J Med 297:669

Thông tin
Thông tin xuất bản

Research in Experimental Medicine

Tập 179

153-161

Thông tin tác giả